Statistics for Evaluation of the Efficacy of M+Pac® in One- and Two-Dose Regimens Against Competitor One-Dose Mycoplasma Hyopneumoniae Bacterins
Total visits
| views | |
|---|---|
| Evaluation of the Efficacy of M+Pac® in One- and Two-Dose Regimens Against Competitor One-Dose Mycoplasma Hyopneumoniae Bacterins | 3 |
Total visits per month
| views | |
|---|---|
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 3 |
| June 2024 | 0 |
| July 2024 | 0 |
File Visits
| views | |
|---|---|
| Groth.pdf | 7 |
Top country views
| views | |
|---|---|
| United States | 3 |
Top city views
| views | |
|---|---|
| Chicago | 3 |